Alcivax #13 – May 29, 2020: Alcimed’s weekly digest of coronavirus news. This week, Alcimed navigates the near future of work debate, its impact on cities, and how it might change what is for dinner ultimately.
Cyber-attacks on French groups are multiplying with the deployment of networks. Production stoppage, rebuilding of systems, affected reputation,… Protean, the impacts end up being quantified. How can we control our cybersecurity to reduce their costly impacts? At Alcimed, we have identified 4 key issues around cybersecurity in order to master the digital world.
Alcimed Position Paper – DIGITAL HEALTH IN TIMES OF PANDEMICS: How will the Covid-19 crisis help build a new place for digital health?
Driven by rapid technological advances, genetic testing is now within the direct reach of consumers. This fast-growing market is pushing many companies to expand, particularly in Asian markets. And yet, the accumulation of data linked to the boom in this activity and their management are already a major challenge.
Air pollution is a subject at the heart of current concerns. For several weeks, researchers and doctors have warned about the correlation between air pollution and sensitivity to respiratory diseases, such as COVID-19. Prolonged and repeated exposure to fine and ultrafine particles damage the mucous membranes of the respiratory tract and the lungs. In this context of health crisis, Alcimed has selected 5 European innovations for you to purify the air in our cities!
Improving knowledge and monitoring of rare diseases is a major public health issue. These diseases are often chronic, serious and affect all medical specialties. Knowledge of rare diseases is therefore difficult for healthcare professionals to acquire. Facing the transformation of the doctor-patient relationship and the patients’ willingness to express themselves and share “their” experience and “their” knowledge about their disease, new horizons are possible for training and knowledge dissemination.
Alcivax #12 – May 20, 2020: Alcimed’s weekly digest of coronavirus news. This week, Alcimed prepares a summer reading list from Machiavelli to Freakonomics to understand the vaccine roller coaster in the COVID-19 context.
We are happy to participate in this webinar that aim at bringing insights on how food can become more sustainable. Bettina, our Business Development Director of Alcimed Asia, will share her knowledge and best practices on the Agrifood market. To contribute to the discussion, we will share the scene with three European companies : Danone, FrieslandCampina Sodexo, that will present their sustainability initiatives and projects, and the World Business Council for Sustainable Development (WBCSD).
CAR T-cell therapies gain more and more attention as being innovative immunotherapy options for cancer patients. Although being researched for years, the approval reach of new treatments is yet limited to certain types of blood cancer. Challenges linked to the therapy are still strong. At Alcimed, we looked at 4 key aspects that will guide you towards the future direction of development in this great field.
High costs of new innovative drugs obviously raise the issue of the capacity of national health insurance systems to finance them, especially as they are often effective in some cases only. The development of those new drugs requires consequently to think beyond the traditional “volume-based” reimbursement model and to go towards an “outcomes-based” reimbursement model in which expensive and selectively working drugs could be prescribed in more cases, even in doubt.
